Cargando…

Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients

BACKGROUND: The anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (moAbs) cetuximab or panitumumab are administered to colorectal cancer (CRC) patients who harbor wild-type RAS proto-oncogenes. However, a percentage of patients do not respond to this treatment. In addition to mutati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lupini, Laura, Bassi, Cristian, Mlcochova, Jitka, Musa, Gentian, Russo, Marta, Vychytilova-Faltejskova, Petra, Svoboda, Marek, Sabbioni, Silvia, Nemecek, Radim, Slaby, Ondrej, Negrini, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624582/ https://www.ncbi.nlm.nih.gov/pubmed/26508446 http://dx.doi.org/10.1186/s12885-015-1752-5

Ejemplares similares

Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy
por: Nemecek, Radim, et al.
Publicado: (2016)

MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab
por: Mlcochova, Jitka, et al.
Publicado: (2015)

Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer
por: Thorenoor, Nithyananda, et al.
Publicado: (2015)

Identification and functional screening of microRNAs highly deregulated in colorectal cancer
por: Faltejskova, Petra, et al.
Publicado: (2012)

Novel classes of non-coding RNAs and cancer
por: Sana, Jiri, et al.
Publicado: (2012)

MiR-215-5p Reduces Liver Metastasis in an Experimental Model of Colorectal Cancer through Regulation of ECM-Receptor Interactions and Focal Adhesion
por: Machackova, Tana, et al.
Publicado: (2020)

MicroRNA Biogenesis Pathway Genes Are Deregulated in Colorectal Cancer
por: Vychytilova-Faltejskova, Petra, et al.
Publicado: (2019)

MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9
por: Vychytilova-Faltejskova, Petra, et al.
Publicado: (2017)

Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients
por: Iliev, Robert, et al.
Publicado: (2016)

MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study
por: Kopkova, Alena, et al.
Publicado: (2018)

miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs
por: Lupini, Laura, et al.
Publicado: (2013)

MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma
por: Vychytilova-Faltejskova, Petra, et al.
Publicado: (2015)

Epigenetic Regulation of MicroRNA Clusters and Families during Tumor Development
por: Gregorova, Jana, et al.
Publicado: (2021)

miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression
por: Ferracin, Manuela, et al.
Publicado: (2013)

Long Non-Coding RNAs in Multiple Myeloma
por: Butova, Romana, et al.
Publicado: (2019)

A comprehensive approach for microbiota and health monitoring in mouse colonies using metagenomic shotgun sequencing
por: Scavizzi, Ferdinando, et al.
Publicado: (2021)

Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing
por: Lupini, Laura, et al.
Publicado: (2022)

MicroRNAs in colorectal cancer: translation of molecular biology into clinical application
por: Slaby, Ondrej, et al.
Publicado: (2009)

Inhibiting the oncogenic mir-221 by microRNA sponge: toward microRNA-based therapeutics for hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2014)

A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein
por: Valianatos, Georgios, et al.
Publicado: (2017)

Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer
por: Slaby, Ondrej, et al.
Publicado: (2012)

MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX
por: Kiss, I., et al.
Publicado: (2017)

Absolute quantification of cell-free microRNAs in cancer patients
por: Ferracin, Manuela, et al.
Publicado: (2015)

High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy
por: Lupini, Laura, et al.
Publicado: (2018)

Long Non-Coding RNAs in Gliomas: From Molecular Pathology to Diagnostic Biomarkers and Therapeutic Targets
por: Vecera, Marek, et al.
Publicado: (2018)

Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma
por: Mlcochova, Hana, et al.
Publicado: (2016)

Germline multigene panel testing of patients with endometrial cancer
por: Kral, Jan, et al.
Publicado: (2023)

Genome‐wide identification of urinary cell‐free microRNAs for non‐invasive detection of bladder cancer
por: Juracek, Jaroslav, et al.
Publicado: (2018)

miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
por: Callegari, Elisa, et al.
Publicado: (2022)

miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
por: Callegari, Elisa, et al.
Publicado: (2022)

Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer
por: Roncarati, Roberta, et al.
Publicado: (2020)

The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients
por: Halamkova, Jana, et al.
Publicado: (2021)

miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eμ-TCL1 mouse model
por: Bresin, Antonella, et al.
Publicado: (2015)

LncRNAs LY86-AS1 and VIM-AS1 Distinguish Plasma Cell Leukemia Patients from Multiple Myeloma Patients
por: Bútová, Romana, et al.
Publicado: (2021)

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients
por: Svoboda, Marek, et al.
Publicado: (2012)

Modular Inducible Multigene Expression System for Filamentous Fungi
por: Baldin, Clara, et al.
Publicado: (2022)

Second primary malignancies in colorectal cancer patients
por: Halamkova, Jana, et al.
Publicado: (2021)

Common polymorphisms in GSTM1, GSTT1, GSTP1, GSTA1 and susceptibility to colorectal cancer in the Central European population
por: Hezova, Renata, et al.
Publicado: (2012)

The Significance of MicroRNAs in the Molecular Pathology of Brain Metastases
por: Siegl, Frantisek, et al.
Publicado: (2022)

Novel Virus Identification through Metagenomics: A Systematic Review
por: Bassi, Cristian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4dh0lgp08f8qdlbv106j944eh7